BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 19847568)

  • 1. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.
    Stacchiotti S; Casali PG; Lo Vullo S; Mariani L; Palassini E; Mercuri M; Alberghini M; Pilotti S; Zanella L; Gronchi A; Picci P
    Ann Surg Oncol; 2010 Jan; 17(1):211-9. PubMed ID: 19847568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decision making in primary sacral tumors.
    Puri A; Agarwal MG; Shah M; Srinivas CH; Shukla PJ; Shrikhande SV; Jambhekar NA
    Spine J; 2009 May; 9(5):396-403. PubMed ID: 19059810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chordoma of the mobile spine: fifty years of experience.
    Boriani S; Bandiera S; Biagini R; Bacchini P; Boriani L; Cappuccio M; Chevalley F; Gasbarrini A; Picci P; Weinstein JN
    Spine (Phila Pa 1976); 2006 Feb; 31(4):493-503. PubMed ID: 16481964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sacral chordoma: retrospective review of 11 surgically treated cases].
    Jeanrot C; Vinh TS; Anract P; De Pinieux G; Ouaknine M; Forest M; Tomeno B
    Rev Chir Orthop Reparatrice Appar Mot; 2000 Nov; 86(7):684-93. PubMed ID: 11104990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Giant cell tumor of the cervical spine: a series of 22 cases and outcomes.
    Junming M; Cheng Y; Dong C; Jianru X; Xinghai Y; Quan H; Wei Z; Mesong Y; Dapeng F; Wen Y; Bin N; Lianshun J; Huimin L
    Spine (Phila Pa 1976); 2008 Feb; 33(3):280-8. PubMed ID: 18303460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical treatment of sacral chordoma: survival and prognostic factors.
    Ruosi C; Colella G; Di Donato SL; Granata F; Di Salvatore MG; Fazioli F
    Eur Spine J; 2015 Nov; 24 Suppl 7():912-7. PubMed ID: 26458933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse.
    Fagundes MA; Hug EB; Liebsch NJ; Daly W; Efird J; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):579-84. PubMed ID: 7558946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. En bloc excisions of chordomas in the cervical spine: review of five consecutive cases with more than 4-year follow-up.
    Hsieh PC; Gallia GL; Sciubba DM; Bydon A; Marco RA; Rhines L; Wolinsky JP; Gokaslan ZL
    Spine (Phila Pa 1976); 2011 Nov; 36(24):E1581-7. PubMed ID: 22048652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sacral chordoma: a clinical review of 101 cases with 30-year experience in a single institution.
    van Wulfften Palthe ODR; Tromp I; Ferreira A; Fiore A; Bramer JAM; van Dijk NC; DeLaney TF; Schwab JH; Hornicek FJ
    Spine J; 2019 May; 19(5):869-879. PubMed ID: 30445184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
    Fiore M; Grosso F; Lo Vullo S; Pennacchioli E; Stacchiotti S; Ferrari A; Collini P; Lozza L; Mariani L; Casali PG; Gronchi A
    Cancer; 2007 Jun; 109(12):2522-31. PubMed ID: 17510918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of sacral chordoma: prognostic variables for local recurrence and overall survival.
    Varga PP; Szövérfi Z; Fisher CG; Boriani S; Gokaslan ZL; Dekutoski MB; Chou D; Quraishi NA; Reynolds JJ; Luzzati A; Williams R; Fehlings MG; Germscheid NM; Lazary A; Rhines LD
    Eur Spine J; 2015 May; 24(5):1092-101. PubMed ID: 25533857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of carbon ion radiotherapy for sacral chordoma: results of Phase I-II and Phase II clinical trials.
    Imai R; Kamada T; Tsuji H; Sugawara S; Serizawa I; Tsujii H; Tatezaki S;
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1470-6. PubMed ID: 19939576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival.
    Ozyar E; Gurkaynak M; Yildiz F; Atahan IL
    Radiother Oncol; 2004 Jul; 72(1):71-7. PubMed ID: 15236877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein as a prognostic factor in patients with chordoma of lumbar spine and sacrum--a single center pilot study.
    Hobusch GM; Bodner F; Walzer S; Marculescu R; Funovics PT; Sulzbacher I; Windhager R; Panotopoulos J
    World J Surg Oncol; 2016 Apr; 14():111. PubMed ID: 27091202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients.
    Bergh P; Kindblom LG; Gunterberg B; Remotti F; Ryd W; Meis-Kindblom JM
    Cancer; 2000 May; 88(9):2122-34. PubMed ID: 10813725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobile spine chordoma: results of 166 patients from the AOSpine Knowledge Forum Tumor database.
    Gokaslan ZL; Zadnik PL; Sciubba DM; Germscheid N; Goodwin CR; Wolinsky JP; Bettegowda C; Groves ML; Luzzati A; Rhines LD; Fisher CG; Varga PP; Dekutoski MB; Clarke MJ; Fehlings MG; Quraishi NA; Chou D; Reynolds JJ; Williams RP; Kawahara N; Boriani S
    J Neurosurg Spine; 2016 Apr; 24(4):644-51. PubMed ID: 26682601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization.
    Yang H; Zhu L; Ebraheim NA; Liu X; Castillo S; Tang T; Liu J; Cui H
    Spine J; 2009 Dec; 9(12):972-80. PubMed ID: 19800296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What Are the Conditional Survival and Functional Outcomes After Surgical Treatment of 115 Patients With Sacral Chordoma?
    Ji T; Guo W; Yang R; Tang X; Wang Y; Huang L
    Clin Orthop Relat Res; 2017 Mar; 475(3):620-630. PubMed ID: 26975382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference Centers.
    Radaelli S; Stacchiotti S; Ruggieri P; Donati D; Casali PG; Palmerini E; Collini P; Gambarotti M; Porcu L; Boriani S; Gronchi A; Picci P
    Spine (Phila Pa 1976); 2016 Jun; 41(12):1049-1057. PubMed ID: 27054448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution.
    Mussi C; Collini P; Miceli R; Barisella M; Mariani L; Fiore M; Casali PG; Gronchi A
    Cancer; 2008 Oct; 113(7):1657-65. PubMed ID: 18704991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.